The down-regulation of the GH/IGF-1/insulin system decreases cancer risk and increases longevity in animal models; however, in humans the results are somewhat contradictory, although genetic studies of the GH/IGF-1/insulin system support their involvement in human longevity [31]. Here, IGF1 is linked to cancer.